Taro appoints new chairman
Kal Sundaram has been named chairman of the board of directors at Taro Pharmaceutical Industries Ltd.
Supplier News
Lay’s unveils BLT-flavored chips
This month Frito-Lay plans to roll out Lay’s Classic BLT-flavored potato chips, which blend the taste of a bacon, lettuce and tomato sandwich with a potato chip.
PhRMA names Lilly’s Lechleiter as chairman
John Lechleiter, chairman and chief executive officer of Eli Lilly and Co., has been elected chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA). PhRMA announced Lechleiter’s election to post on Friday at its annual meeting in Boston.
Perrigo releases generic Mucinex
Perrigo Co. has begun shipping guaifenesin extended-release tablets 600 mg, a generic version of Mucinex tablets. Perrigo said the launch entails product packaged in bottles "to a number of customers.
Mylan ships Lescol generic version
Mylan Inc. has been cleared to market fluvastatin capsules, a treatment for high cholesterol. The company said Friday that its Mylan Pharmaceuticals Inc.
AstraZeneca launches Dutoprol
AstraZeneca has introduced Dutoprol Tablets, an anti-hypertension medication that the company described as the first and only once-daily combination with the active ingredient of Toprol-XL (metoprolol succinate) extended-release tablets plus low-dose hydrochlorothiazide, offering the dual efficacy o
VA tabs McKesson as prime Rx supplier
McKesson Corp. has been selected by the Department of Veterans Affairs to continue as its prime pharmaceutical supplier.
Prasco to roll out vancomycin capsules
Prasco Laboratories is releasing an authorized generic version of Vancocin Hydrochloride Capsules. Prasco said Wednesday that it will exclusively sell and distribute the authorized generic, which comes in strengths of 125 mg and 250 mg, as part of a distribution and supply pact with ViroPharma Inc.
Takeda to acquire URL Pharma
Takeda Pharmaceutical Co. plans to buy URL Pharma Inc. for $800 million. The companies said Wednesday that the deal, which also includes future performance-based payments to Takeda, is expected to close within the next couple of months.
Watson, Akorn release generic Vancocin
Watson Pharmaceuticals Inc. and Akorn Inc. have shipped vancomycin hydrochloride capsules, an antibiotic used to treat infections of the intestines that cause colitis. The companies said Tuesday that their products, offered in strengths of 125 mg and 250 mg, are generic versions of ViroPharma Inc.
Cardinal’s Pharmacy Health Network has impact
Cardinal Health Inc. said its digital advertising network for retail pharmacies has been shown by Nielsen Co. audience research to be an effective way for advertisers to market products to consumers at the point of purchase.
Dream Water lands distribution with major chains
Dream Products LLC has expanded distribution of its Dream Water relaxation shot to Target, Kroger and Safeway stores.
Mylan ships generic version of Tricor
Mylan Inc. has released fenofibrate tablets, a treatment for high cholesterol and triglycerides, in strengths of 48 mg and 145 mg. The company said Friday that its Mylan Pharmaceuticals Inc.
Energizer ups performance of AA lithium battery
Energizer Holdings Inc. has boosted the performance of its Energizer Ultimate Lithium AA batteries, which the company said are already the longest-lasting AAs in high-tech devices.
Teva set to ship ‘dry’ allergy nasal spray
Teva Pharmaceutical Industries has been cleared by the Food and Drug Administration to market QNASL Nasal Aerosol, a "dry" nasal aerosol corticosteroid that treats seasonal and year-round nasal allergy symptoms.
Bausch+Lomb to acquire Ista Pharmaceuticals
Bausch+Lomb has unveiled a $500 million deal to acquire Ista Pharmaceuticals Inc., a maker of branded prescription drugs for eye care. Bausch+Lomb said Monday that the transaction, which has been unanimously approved by the boards of both companies, is slated to close in the second quarter.